EMCURE PHARMACEUTICALS
Back to Cashflow Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹343 Cr | ₹-814 Cr | ₹-164 Cr | ₹-145 Cr | ₹-152 Cr |
What is the latest Cash Flow from Financing Activities ratio of EMCURE PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹343 Cr |
| Mar2025 | ₹-814 Cr |
| Mar2024 | ₹-164 Cr |
| Mar2023 | ₹-145 Cr |
| Mar2022 | ₹-152 Cr |
How is Cash Flow from Financing Activities of EMCURE PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹343 Cr | Positive | |
| Mar2025 | ₹-814 Cr | Negative | |
| Mar2024 | ₹-164 Cr | Negative | |
| Mar2023 | ₹-145 Cr | Negative | |
| Mar2022 | ₹-152 Cr | - | |
Compare Cash Flow from Financing Activities of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹35,435.0 Cr | -3.1% | -2.7% | 27.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,466.0 Cr | -2.3% | -5.9% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,222.0 Cr | -1.7% | -1.1% | 60.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | -2.1% | -5.1% | 32.2% | Stock Analytics | |
| CIPLA | ₹107,447.0 Cr | -2.2% | -4% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,471.0 Cr | 1.8% | 7.6% | -4.3% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -3.1% |
-2.7% |
27.9% |
| SENSEX | -0.1% |
-2.3% |
-10.7% |
You may also like the below Video Courses